Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and Roche Holding AG (OtherRHHVF)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Protagonist Therapeutics (PTGX – Research Report) and Roche ...
MyChesCo on MSN23h
FDA Approves Lifesaving Stroke Drug, Xarelto Generics, and Issues Urgent Testosterone Warnings
The U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and ...
EMS13d
FDA approves clot-dissolving agent for treatment of acute ischemic stroke
TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...
EMS13d
Ill. FD’s non-emergency EMS unit saves residents over $5M in first year
Naperville's CART started full-time service in January, responding to mental health crises and community paramedicine calls ...
Physician's Weekly3d
Suicide Prevention Organizations Do Not Target Older Adults
Despite acknowledging that older adults are a high-risk population for suicide, the websites of suicide prevention ...
Health and Me on MSN3d
FDA Approves TNKase To Treat Ischemic Strokes In Adults
It is delivered as a single five-second intravenous bolus, which is faster than the standard of care Activase or alteplase, ...
FDA Approves TNKase for Acute Ischemic Stroke
THURSDAY, March 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a ...
MPR4d
TNKase Approved for Treatment of Acute Ischemic Stroke
The approval was supported by data from the registry-linked, parallel group, open-label, randomized AcT trial, which compared tenecteplase to alteplase.
News-Medical.Net4d
Chronic stress may raise stroke risk for younger women
Some people living with chronic stress have a higher risk of stroke, according to a study published on March 5, 2025, online in Neurology, the medical journal of the American Academy of Neurology.
PMLive5d
Roche’s Genentech granted FDA approval for TNKase in acute ischaemic stroke
Roche’s Genentech unit has received approval from the US Food and Drug Administration (FDA) for TNKase (tenecteplase) in ...
Medical Dialogues5d
FDA Approves Tenecteplase as First Stroke Drug in Nearly 30 Years
The US Food and Drug Administration has approved Tenecteplase as first FDA-approved stroke medication in nearly three decades ...
Roche Gets FDA Approval for Acute Ischemic Stroke Drug for Adults
RHHBY's member company, Genentech, obtains FDA nod for TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.